Business Description
Cytophage Technologies Ltd
NAICS : 541713
SIC : 3741
Description
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.45 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38 | |||||
| 9-Day RSI | 35.45 | |||||
| 14-Day RSI | 36.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.48 | |||||
| Quick Ratio | 3.48 | |||||
| Cash Ratio | 1.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -75.64 | |||||
| ROA % | -68.77 | |||||
| ROIC % | -161.83 | |||||
| ROC (Joel Greenblatt) % | -190.27 | |||||
| ROCE % | -75.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 12.8 | |||||
| Price-to-Tangible-Book | 10.67 | |||||
| EV-to-EBIT | -9.22 | |||||
| EV-to-EBITDA | -10.41 | |||||
| EV-to-FCF | -17.56 | |||||
| Price-to-Net-Current-Asset-Value | 32 | |||||
| Earnings Yield (Greenblatt) % | -10.85 | |||||
| FCF Yield % | -5.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cytophage Technologies Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.034 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 36.48 | ||
| 14-Day ATR (C$) | 0.038355 | ||
| 20-Day SMA (C$) | 0.3815 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.305 - 0.76 | ||
| Shares Outstanding (Mil) | 53.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cytophage Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cytophage Technologies Ltd Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cytophage Technologies Ltd Frequently Asked Questions
What is Cytophage Technologies Ltd(TSXV:CYTO)'s stock price today?
The current price of TSXV:CYTO is C$0.32. The 52 week high of TSXV:CYTO is C$0.76 and 52 week low is C$0.31.
When is next earnings date of Cytophage Technologies Ltd(TSXV:CYTO)?
The next earnings date of Cytophage Technologies Ltd(TSXV:CYTO) is .
Does Cytophage Technologies Ltd(TSXV:CYTO) pay dividends? If so, how much?
Cytophage Technologies Ltd(TSXV:CYTO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers